Initial findings prove that 17-DMAG specifically kills disease-causing lymphocyte populations in lupus models such as follicular B cells and double-negative T cells (CD4-CD8-), thus improving immune imbalance in aging models (84). Here, CD8A is linked to systemic lupus erythematosus.